showed a trendP = 0.066
rate control in the primary endpoint of all-cause death or HF event but showed a trend in a similar direction as the other trials [23% vs. 33%, HR (95% CI) 0.71 (0.49–1.03), P = 0.066; n = 411].
rate control in the primary endpoint of all-cause death or HF event but showed a trend in a similar direction as the other trials [23% vs. 33%, HR (95% CI) 0.71 (0.49–1.03), P = 0.066; n = 411].